Exosome Diagnostics and Therapeutics Market Size, Share 2031
Exosome Diagnostics and Therapeutics Market Size, Share 2031
Segments - Global Exosome Diagnostics and Therapeutics Market by Applications (Diagnostics and Therapeutics), Products (Instruments, Reagents, and Software), End-users (Cancer Institutes, Hospitals, Diagnostic Centers, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-4440
| 4.5 Rating
| 70 Reviews
| 176 Pages
| Format :
Report Description
Exosome Diagnostics and Therapeutics Market Outlook 2031
The Exosome Diagnostics and Therapeutics Market was USD 375.64 Million in 2022 and is likely to reach USD 3.82 Billion by 2031, expanding at a CAGR of 29.4% during 2023 – 2031. Exosomes are responsible for supporting cell-to-cell communication in the cancer prognosis. They suppress the immune function by initiating the apoptosis of activated cytotoxic T cells, which assist tumor development in the human body.
Market Trends, Drivers, Restraints, and Opportunities
- Growing focus on life science research and increasing diagnostic procedures for cancer are key factors driving the growth of the market.
- Increasing prevalence of cancer, technological advancements, and rising emphasis on early diagnosis of cancer are some of the major factors driving the market growth
- Rising number of initiatives taken by governments and non-government organizations in spreading awareness regarding cancer diagnosis and therapeutics are spurring the growth of the market.
- Favorable reimbursement scenario regarding cancer treatment in emerging economies is anticipated to positively influence the market growth in the coming years.
- High cost of the diagnostic procedures and rising occurrence of cancer in low income groups can inhibit the market growth during the forecast period.
- Lack of awareness and stringent regulations for the approval of products can create challenges for the market growth.
- Emerging countries such as India and China are likely to create tremendous growth opportunities for the market in the projected timeline.
Scope of Exosome Diagnostics and Therapeutics Market Report
The report on the global exosome diagnostics and therapeutics market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
|
Attributes |
Details |
|
Report Title |
Exosome Diagnostics and Therapeutics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016 - 2021 |
|
Forecast Period |
2023 – 2031 |
|
Segmentation |
Applications (Diagnostics and Therapeutics), Products (Instruments, Reagents, and Software), End-users (Cancer Institutes, Hospitals, Diagnostic Centers, and Others) |
|
Regional Scope |
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
|
Report Coverage |
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
|
Key Players Covered |
Aethlon Medical Inc., NanoSomix Inc., Malvern Instruments Ltd., Thermo Fisher Scientific Inc., System Biosciences Inc., Exosome Diagnostics Inc., Systemics Inc., and NX Pharmagen |
Exosome Diagnostics and Therapeutics Market Segment Insights
Diagnostics segment is projected to expand a high CAGR
On the basis of applications, the market can be bifurcated into diagnostics and therapeutics. The diagnostics segment is projected to exhibit a high CAGR during the forecast period, and dominated the exosome diagnostic and therapeutic market in 2020. Exosomes occurs under both pathological as well as normal conditions and carry nucleic acid from the host eukaryotic cells that are widely considered to be crucial for clinical diagnostics.
A diagnostic procedure determines specific area of an individual that have weakness and strength in order to diagnose the condition or disease. Genetic information is collected by diagnostic tests from exosomes of patients to provide real time information about the presence of tumor to aid in the accurate diagnosis. These tests are of high importance as it helps in high awareness of diagnosis and treatment procedures.
Hospitals segment to constitute for a major market share
In terms of end-users, the market can be segregated into cancer institutes, hospitals, diagnostic centers, and others. The hospitals segment to constitute for a major market share and is estimated to expand at a CAGR 14.2% during the forecast period. Huge availability of instruments and reagents along with the high-end technological products is estimated to drive the segment market growth.
Moreover, growing demand for immunization, availability of highly skilled and qualified medical professionals in the hospitals along with the rising cases of cancer are contributing revenue to hospitals. Favorable reimbursement policies for hospital procedures and improvements in healthcare facilities are further increasing demand for hospitals. On the other hand, the cancer institutes segment is estimated to register a high CAGR during the forecast period.
Instrument segment to exhibit a CAGR during the forecasted period
On the basis of products, the market can be segmented into Instruments, Reagents, and Software. The Instrument segment is estimated to exhibit a CAGR during the forecasted period. Instruments are widely used in the cure and identification of cancer. Growing unhealthy lifestyle and the prevalence of cancer have increased the demand for instruments in the market.
North America is anticipated to account a significant market share
Based on regions, the market is divided into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to account a significant market share. The rapidly growing geriatric population and rising incidence of chronic diseases such as cancer and cardiovascular disorders are the primary factors driving the regional market growth. Moreover, ongoing technological advancements in the isolation of exosomes are working in favor of the growth of the market in North America.
Segments
Applications
- Diagnostics
- Therapeutics
Products
- Instruments
- Reagents
- Software
End-users
- Cancer Institutes
- Hospitals
- Diagnostic Centers
- Others
Regions
- Asia Pacific
- North America
- Europe
- Latin America
- Middle East & Africa
Key Players
- Aethlon Medical Inc.
- NanoSomix Inc.
- Malvern Instruments Ltd.
- Thermo Fisher Scientific Inc.
- System Biosciences Inc.
- Exosome Diagnostics Inc.
- Systemics Inc.
- NX Pharmagen
Competitive Landscape
Some of the key companies operating in the market are Aethlon Medical Inc., NanoSomix Inc., Malvern Instruments Ltd., Thermo Fisher Scientific Inc., System Biosciences Inc., Exosome Diagnostics Inc., Systemics Inc., and NX Pharmagen.
The global leaders in the exosome diagnostic and therapeutic market are aiming to increase their market share by grabbing immense potential offered in emerging regions. Players are focusing toward introducing innovative products to improve their visibility in the market. Partnerships and achievements are composed to remain key growth strategies for prominent players.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Exosome Diagnostics and Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Exosome Diagnostics and Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Exosome Diagnostics and Therapeutics Market - Supply Chain
4.5. Global Exosome Diagnostics and Therapeutics Market Forecast
4.5.1. Exosome Diagnostics and Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Exosome Diagnostics and Therapeutics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Exosome Diagnostics and Therapeutics Market Absolute $ Opportunity
5. Global Exosome Diagnostics and Therapeutics Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Exosome Diagnostics and Therapeutics Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Exosome Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
6. North America Exosome Diagnostics and Therapeutics Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Exosome Diagnostics and Therapeutics Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Exosome Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
7. Latin America Exosome Diagnostics and Therapeutics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Exosome Diagnostics and Therapeutics Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Exosome Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
8. Europe Exosome Diagnostics and Therapeutics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Exosome Diagnostics and Therapeutics Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Exosome Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
9. Asia Pacific Exosome Diagnostics and Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Exosome Diagnostics and Therapeutics Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Exosome Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
10. Middle East & Africa Exosome Diagnostics and Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Exosome Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Exosome Diagnostics and Therapeutics Market: Market Share Analysis
11.2. Exosome Diagnostics and Therapeutics Distributors and Customers
11.3. Exosome Diagnostics and Therapeutics Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Aethlon Medical Inc.
11.4.2. NanoSomix Inc.
11.4.3. Malvern Instruaments Ltd.
11.4.4. Thermo Fisher Scientific Inc.
11.4.5. System Biosciences Inc.
11.4.6. Exosome Diagnostics Inc.
11.4.7. Systemics Inc.
Methodology
Related Reports
Some other reports from this category!
Our Clients
